Mitochondrial sensitive probe with aggregation-induced emission characteristics for early brain diagnosis of Parkinson’s disease

Liwen Huang , Yutong Zhou , Di Jiao , Jing Ren , Yilin Qi , Heping Wang , Yang Shi , Dan Ding , Xue Xue

Aggregate ›› 2024, Vol. 5 ›› Issue (1) : 403

PDF
Aggregate ›› 2024, Vol. 5 ›› Issue (1) :403 DOI: 10.1002/agt2.403
RESEARCH ARTICLE
Mitochondrial sensitive probe with aggregation-induced emission characteristics for early brain diagnosis of Parkinson’s disease
Author information +
History +
PDF

Abstract

The early diagnosis of Parkinson’s disease (PD) provides opportunities for early intervention to slow the progression of neurological degeneration in patients, particularly as the aging population increases in our society. Among a series of pathological features of PD, mitochondria abnormalities have been identified as central event that occurs at the early stage of PD. However, the method for detecting mitochondrial abnormalities-associated early PD has not been fully developed. We herein report a specifically mitochondrial targeting probe (named TPA-BT-SCP) that is able to characterize mitochondria abnormalities for early diagnosis of PD and monitor PD neurodegenerative progress. The probe is an aggregation-induced emission (AIE) probe with a strong positive charge, a 3D distorted molecular structure, and a separated HOMO-LUMO distribution, designed with unique molecular design guidelines. Our research demonstrated that TPA-BT-SCP could emit stable and strong fluorescence, and rapidly accumulate in mitochondria due to the negative charge. After intranasal administration of 1-methy-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mice, TPA-BT-SCP successfully bypassed the blood−brain barrier to light up the brain, allowing the grading of PD severity based on its high sensitivity. Taken together, this work develops a novel AIE probe that exhibits dramatically high sensitivity to mitochondrial changes and enables noninvasive diagnosis of early PD in the brain.

Keywords

aggregation-induced emission / early diagnosis / Parkinson’s disease

Cite this article

Download citation ▾
Liwen Huang, Yutong Zhou, Di Jiao, Jing Ren, Yilin Qi, Heping Wang, Yang Shi, Dan Ding, Xue Xue. Mitochondrial sensitive probe with aggregation-induced emission characteristics for early brain diagnosis of Parkinson’s disease. Aggregate, 2024, 5(1): 403 DOI:10.1002/agt2.403

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

B. R. Bloem, M. S. Okun, C. Klein, Lancet 2021, 397, 2284.

[2]

T. Li, W. Le, Neurosci. Bull. 2020, 36, 2.

[3]

E. Tolosa, A. Garrido, S. W. Scholz, W. Poewe, Lancet Neurol. 2021, 20, 385.

[4]

M. V. Ugrumov, V. G. Khaindrava, E. A. Kozina, V. G. Kucheryanu, E. V. Bocharov, G. N. Kryzhanovsky, V. S. Kudrin, V. B. Narkevich, P. M. Klodt, K. S. Rayevsky, T. S. Pronina, Neuroscience 2011, 181, 175.

[5]

N. Vijiaratnam, T. Simuni, O. Bandmann, H. R. Morris, T. Foltynie, Lancet Neurol. 2021, 20, 559.

[6]

GBDN Collaborators, Lancet Neurol. 2019, 18, 5.

[7]

S. H. Fox, R. Katzenschlager, S. Y. Lim, B. Barton, R. M. A. de Bie, K. Seppi, M. Coelho, C. Sampaio, Mov. Disord. 2018, 33, 1248.

[8]

A. Merola, E. A. Coon, Clin. Auton. Res. 2020, 30, 191.

[9]

S. Chen, P. Chan, S. Sun, H. Chen, B. Zhang, W. Le, C. Liu, G. Peng, B. Tang, L. Wang, Y. Cheng, M. Shao, Z. Liu, Z. Wang, X. Chen, M. Wang, X. Wan, H. Shang, Y. Liu, P. Xu, J. Wang, T. Feng, X. Chen, X. Hu, A. Xie, Q. Xiao, Transl. Neurodegener. 2016, 5, 12.

[10]

M. Naoi, W. Maruyama, M. Shamoto-Nagai, Int. J. Mol. Sci. 2022, 23, 11059.

[11]

M. A. C Sy, H. H. Fernandez, Neurotherapeutics 2020, 17, 1331.

[12]

C. E. Toomey, W. E. Heywood, J. R. Evans, J. Lachica, S. N. Pressey, S. C. Foti, M. Al Shahrani, K. D’Sa, I. P. Hargreaves, S. Heales, M. Orford, C. Troakes, J. Attems, E. Gelpi, M. Palkovits, T. Lashley, S. M. Gentleman, T. Revesz, K. Mills, S. Gandhi, Acta Neuropathol. Commun. 2022, 10, 134.

[13]

A. K. Alieva, V. S. Zyrin, M. M. Rudenok, A. A. Kolacheva, M. V. Shulskaya, M. V. Ugryumov, P. A. Slominsky, M. I. Shadrina, Mol. Neurobiol. 2018, 55, 7229.

[14]

J. Jankovic, E. K. Tan, J. Neurol. Neurosurg. Psychiatry 2020, 91, 8.

[15]

K. Kalinderi, S. Bostantjopoulou, L. Fidani, Acta Neurol. Scand. 2016, 134, 314.

[16]

C. Klein, A. Westenberger, Cold Spring Harb. Perspect. Med. 2012, 2, a008888.

[17]

A. M. Pickrell, R. J. Youle, Neuron 2015, 85, 257.

[18]

Y. Zhang, H. Yang, D. Wei, X. Zhang, J. Wang, X. Wu, J. Chang, Exploration 2021, 1, 3.

[19]

N. A. Y Haelterman, H. Sandoval, M. Jaiswal, J. M. Shulman, H. J. Bellen, Annu. Rev. Neurosci. 2014, 37, 137.

[20]

G. A. Smith, O. Isacson, S. B. Dunnett, Exp. Neurol. 2012, 237, 267.

[21]

J. Magalhaes, E. Tresse, P. Ejlerskov, E. Hu, Y. Liu, A. Marin, A. Montalant, L. Satriano, C. F. Rundsten, E. M. M. Carlsen, R. Rydbirk, A. Sharifi-Zarchi, J. B. Andersen, S. Aznar, T. Brudek, K. Khodosevich, M. Prinz, J. M. Perrier, M. Sharma, T. Gasser, S. Issazadeh-Navikas, Mol. Psychiatry 2021, 26, 10.

[22]

J. Chen, Y. Lu, Y. Wu, Z. Chen, X. Liu, C. Zhang, J. Sheng, L. Li, W. Chen, X. Song, ACS Chem. Neurosci. 2021, 12, 21.

[23]

L. Li, C. W. Zhang, G. Y. Chen, B. Zhu, C. Chai, Q. H. Xu, E. K. Tan, Q. Zhu, K. L. Lim, S. Q. Yao, Nat. Commun. 2014, 5, 3276.

[24]

S. Creed, M. McKenzie, Methods Mol. Biol. 2019, 1928, 2.

[25]

J. F. Lovell, T. W. Liu, J. Chen, G. Zheng, Chem. Rev. 2010, 110, 2839.

[26]

W. Fan, P. Huang, X. Chen, Chem. Soc. Rev. 2016, 45, 23.

[27]

C. Chen, X. Ni, S. Jia, Y. Liang, X. Wu, D. Kong, D. Ding, Adv. Mater. 2019, 31, 52.

[28]

J. Miao, M. Miao, Y. Jiang, M. Zhao, Q. Li, Y. Zhang, Y. An, K. Pu, Q. Miao, Angew. Chem. Int. Ed. 2023, 62, 7.

[29]

L. F. J Qi, X. Zhang, H. Zhang, L. Huang, Y. Zhou, Z. Zhao, X. Duan, F. Xu, R. T. K. Kwok, J. W. Y. Lam, D. Ding, X. Xue, B. Tang, Nat. Commun. 2021, 12, 960.

[30]

K. McDowell, M. F. Chesselet, Neurobiol. Dis. 2012, 46, 597.

[31]

J. N. Guzman, E. Ilijic, B. Yang, J. Sanchez-Padilla, D. Wokosin, D. Galtieri, J. Kondapalli, P. T. Schumacker, D. J. Surmeier, J. Clin. Invest. 2018, 128, 2266.

[32]

H. Bernheimer, W. Birkmayer, O. Hornykiewicz, K. Jellinger, F. Seitelberger, J. Neurol. Sci. 1973, 20, 415.

[33]

V. Jackson-Lewis, S. Przedborski, Nat. Protoc. 2007, 2, 141.

[34]

P. C. Pires, A. O. Santos, J. Control. Release 2018, 270, 89.

[35]

R. Y. Lin, C. P. Lee, Y. C. Chen, J. D. Peng, T. C. Chu, H. H. Chou, H. M. Yang, J. T. Lin, K. C. Ho, Chem. Commun. 2012, 48, 99.

[36]

C. Y. Yu, H. Xu, S. Ji, R. T. Kwok, J. W. Lam, X. Li, S. Krishnan, D. Ding, B. Z. Tang, Adv. Mater. 2017, 29, 15.

[37]

W. J. Nicklas, I. Vyas, R. E. Heikkila, Life Sci. 1985, 36, 2503.

[38]

C. Gai, W. D. Feng, T. Y. Qiang, H. J. Ma, Y. Chai, S. J. Zhang, Z. Y. Guo, J. H. Hu, H. M. Sun, D.-B.-Y. Wan, Q.-Z. San, Front. Pharmacol. 2019, 10, 372.

[39]

P. Risiglione, L. Leggio, S. A. M. Cubisino, S. Reina, G. Paterno, B. Marchetti, A. Magri, N. Iraci, A. Messina, Int. J. Mol. Sci. 2020, 21, 7809.

[40]

N. A. Tatton, S. J. Kish, Neuroscience 1997, 77, 4.

[41]

J. Jankovic, J. Neurol. Neurosurg. Psychiatry 2008, 79, 368.

[42]

R. D. Prediger, A. S. Aguiar Jr., A. E Rojas-Mayorquin, C. P. Figueiredo, F. C. Matheus, L. Ginestet, C. Chevarin, E. D. Bel, R. Mongeau, M. Hamon, L. Lanfumey, R. Raisman-Vozari, Neurotox. Res. 2010, 17, 114.

[43]

S. Franco-Iborra, T. Cuadros, A. Parent, J. Romero-Gimenez, M. Vila, C. Perier, Cell Death Dis. 2018, 9, 11.

[44]

N. Hada, W. J. Netzer, F. Belhassan, L. P. Wennogle, S. Gizurarson, Eur. J. Pharm. Sci. 2017, 102, 46.

[45]

J. Born, T. Lange, W. Kern, G. P. McGregor, U. Bickel, H. L. Fehm, Nat. Neurosci. 2002, 5, 514.

[46]

X. Q. Chen, J. R. Fawcett, Y. E. Rahman, T. A. Ala, I. W. Frey, J. Alzheimer’s Dis. 1998, 1, 35.

[47]

R. G. Thorne, G. J. Pronk, V. Padmanabhan, W. H. Frey 2nd, Neuroscience 2004, 127, 481.

[48]

R. De Rosa, A. A. Garcia, C. Braschi, S. Capsoni, L. Maffei, N. Berardi, A. Cattaneo, Proc. Natl. Acad. Sci. U. S. A. 2005, 102, 3811.

[49]

M. Agrawal, S. Saraf, S. Saraf, S. G. Antimisiaris, M. B. Chougule, S. A. Shoyele, A. Alexander, J. Control. Release 2018, 281, 139.

[50]

I. Kaur, T. Behl, A. Sehgal, S. Singh, N. Sharma, L. Aleya, S. Bungau, Environ. Sci. Pollut. Res. Int. 2021, 28, 28.

[51]

E. Zampese, D. J. Surmeier, Cells 2020, 9, 2045.

[52]

M. R. Patel, R. B. Patel, K. K. Bhatt, B. G. Patel, R. V. Gaikwad, Drug Deliv. 2016, 23, 1.

[53]

V. Bourganis, O. Kammona, A. Alexopoulos, C. Kiparissides, Eur. J. Pharm. Biopharm. 2018, 128, 337.

[54]

R. A. Yokel, Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2022, 14, 2.

[55]

L. R. Hanson, W. H. Frey 2nd, BMC Neurosci. 2008, 9, 1.

[56]

R. M. Gallagher, Arch. Neurol. 1996, 53, 1285.

[57]

T. P. Crowe, M. H. W. Greenlee, A. G. Kanthasamy, W. H. Hsu, Life Sci. 2018, 195, 44.

[58]

F. Erdo, L. A. Bors, D. Farkas, A. Bajza, S. Gizurarson, Brain Res. Bull. 2018, 143, 155.

[59]

L. A. Keller, O. Merkel, A. Popp, Drug Deliv. Transl. Res. 2022, 12, 735.

[60]

T. Guo, Y. Guo, Y. Gong, J. Ji, S. Hao, J. Deng, B. Wang, Int. J. Pharm. 2019, 566, 46.

RIGHTS & PERMISSIONS

2023 The Authors. Aggregate published by SCUT, AIEI, and John Wiley & Sons Australia, Ltd.

PDF

310

Accesses

0

Citation

Detail

Sections
Recommended

/